Literature DB >> 11786019

Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.

Martino L di Salvo1, Tzu-Ping Ko, Faik N Musayev, Samanta Raboni, Verne Schirch, Martin K Safo.   

Abstract

Pyridoxine-5'-phosphate oxidase catalyzes the oxidation of either the C4' alcohol group or amino group of the two substrates pyridoxine 5'-phosphate and pyridoxamine 5'-phosphate to an aldehyde, forming pyridoxal 5'-phosphate. A hydrogen atom is removed from C4' during the oxidation and a pair of electrons is transferred to tightly bound FMN. A new crystal form of the enzyme in complex with pyridoxal 5'-phosphate shows that the N-terminal segment of the protein folds over the active site to sequester the ligand from solvent during the catalytic cycle. Using (4'R)-[(3)H]PMP as substrate, nearly 100 % of the radiolabel appears in water after oxidation to pyridoxal 5'-phosphate. Thus, the enzyme is specific for removal of the proR hydrogen atom from the prochiral C4' carbon atom of pyridoxamine 5'-phosphate. Site mutants were made of all residues at the active site that interact with the oxygen atom or amine group on C4' of the substrates. Other residues that make interactions with the phosphate moiety of the substrate were mutated. The mutants showed a decrease in affinity, but exhibited considerable catalytic activity, showing that these residues are important for binding, but play a lesser role in catalysis. The exception is Arg197, which is important for both binding and catalysis. The R197 M mutant enzyme catalyzed removal of the proS hydrogen atom from (4'R)-[(3)H]PMP, showing that the guanidinium side-chain plays an important role in determining stereospecificity. The crystal structure and the stereospecificity studies suggests that the pair of electrons on C4' of the substrate are transferred to FMN as a hydride ion. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786019     DOI: 10.1006/jmbi.2001.5254

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Molecular basis of reduced pyridoxine 5'-phosphate oxidase catalytic activity in neonatal epileptic encephalopathy disorder.

Authors:  Faik N Musayev; Martino L Di Salvo; Mario A Saavedra; Roberto Contestabile; Mohini S Ghatge; Alexina Haynes; Verne Schirch; Martin K Safo
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

2.  Allosteric feedback inhibition of pyridoxine 5'-phosphate oxidase from Escherichia coli.

Authors:  Anna Barile; Angela Tramonti; Martino Luigi di Salvo; Isabel Nogués; Caterina Nardella; Francesco Malatesta; Roberto Contestabile
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

3.  The molecular structure of Rv2074, a probable pyridoxine 5'-phosphate oxidase from Mycobacterium tuberculosis, at 1.6 angstroms resolution.

Authors:  Bichitra K Biswal; Karolyn Au; Maia M Cherney; Craig Garen; Michael N G James
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-07-24

4.  Treponema denticola cystalysin exhibits significant alanine racemase activity accompanied by transamination: mechanistic implications.

Authors:  Mariarita Bertoldi; Barbara Cellini; Alessandro Paiardini; Martino Di Salvo; Carla Borri Voltattorni
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

5.  Structure and properties of recombinant human pyridoxine 5'-phosphate oxidase.

Authors:  Faik N Musayev; Martino L Di Salvo; Tzu-Ping Ko; Verne Schirch; Martin K Safo
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

6.  A pathway for repair of NAD(P)H in plants.

Authors:  Maite Colinas; Holly V Shaw; Sylvain Loubéry; Markus Kaufmann; Michael Moulin; Teresa B Fitzpatrick
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

7.  Identification and characterization of two families of F420 H2-dependent reductases from Mycobacteria that catalyse aflatoxin degradation.

Authors:  Matthew C Taylor; Colin J Jackson; David B Tattersall; Nigel French; Thomas S Peat; Janet Newman; Lyndall J Briggs; Gauri V Lapalikar; Peter M Campbell; Colin Scott; Robyn J Russell; John G Oakeshott
Journal:  Mol Microbiol       Date:  2010-09-16       Impact factor: 3.501

8.  Experimental Evidence for a Revision in the Annotation of Putative Pyridoxamine 5'-Phosphate Oxidases P(N/M)P from Fungi.

Authors:  Tatiana Domitrovic; Diana P Raymundo; Tiago Fernandes da Silva; Fernando L Palhano
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

9.  Inactive mutants of human pyridoxine 5'-phosphate oxidase: a possible role for a noncatalytic pyridoxal 5'-phosphate tight binding site.

Authors:  Mohini S Ghatge; Sayali S Karve; Tanya M S David; Mostafa H Ahmed; Faik N Musayev; Kendra Cunningham; Verne Schirch; Martin K Safo
Journal:  FEBS Open Bio       Date:  2016-03-22       Impact factor: 2.693

10.  Molecular characterization of pyridoxine 5'-phosphate oxidase and its pathogenic forms associated with neonatal epileptic encephalopathy.

Authors:  Anna Barile; Isabel Nogués; Martino L di Salvo; Victoria Bunik; Roberto Contestabile; Angela Tramonti
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.